Physician

Matthew James Kahari, MD

According to 2025 Medicare claims, Matthew Kahari, MD (NPI: 1124524350) practices addiction medicine in the Scranton--Wilkes-Barre, PA market, with the plurality of this provider's patient population coming from Lackawanna, PA. This provider's primary affiliated billing organization is GEISINGER CLINIC (NPI: 1639600075; TIN: 236291113) and primary practice location at 18508-2572. Kahari is affiliated with the Keystone ACO (ACO ID: A1552), participating under the MSSP model.

Kahari's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 29 traditional Medicare patients, billed 193 HCPCS/CPT codes, and received $10,565 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 322 prescription claims across 78 beneficiaries totaling $163,736 in drug costs, led by Sublocade (Buprenorphine). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,584 to $163,736. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.